Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin

Hepatology

Volumn 24, Issue 6, 1996, Pages 1327-1333

  Terrault, Norah A ^a,b   Zhou, Shuan ^a,b   Combs, Connie ^a,b   Hahn, Judith A ^b   Lake, John R ^b   Roberts, John P ^b   Ascher, Nancy L ^b   Wright, Teresa L ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LONG TERM CARE; MALE; MYALGIA; NAUSEA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; REINFECTION; VIRUS REPLICATION;

EID: 0029962626     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008938155     Document Type: Article

References (12)

1. O'Grady J, Smith H, Davies S, Daniels H, Donaldson P, Tan K, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. J Hepatol 1992;14:104-111.
2. Todo S, Demetris A, Van Thiel D, Teperman L, Fung J, Starzl T. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. HEPATOLOGY 1991;13:619-626.
3. Samuel D, Bismuth A, Mathieu D, Arulnaden J-P, Reynes M, Benhamou J-P, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991;337:813-815.
4. Levy G, Sherker A, Fung L, Greig P, Sherman M, Blendis L. Relevance of hepatitis B viral DNA in assessment of potential liver allograft recipients. Transplant Proc 1989;21:3333-3334.
5. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou J-P, Bismuth H, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847.
6. Gugenheim J, Crafa F, Fabiani P, Goubaux B, Ouzan D, Mouiel J. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients. Transplant Proc 1993;25: 1349-1350.
7. Muller R, Gubernatis G, Farle M, Niehoff G, Klien H, Wittekind C, et al. Liver transplantation in HBs antigen (HBsAg) carriers: prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991;13:90-96.
8. Mora N, Klintmalm G, Poplawski S, Cofer J, Husberg B, Gonwa TA, Goldstein RM. Recurrence of hepatitis B after liver transplantation: does hepatitis-B immunoglobulin modify the recurrent disease? Transplant Proc 1990;22:1549-1550.
9. Rimoldi P, Belli L, Rondinara G, Alberti A, DeCarlis L, Minola E, et al. Recurrent HBV/HDV infections under different immune-prophylaxis protocols. Transplant Proc 1993;25:2675-2676.
10. Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts J, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343:142-146.
11. Wright T, Donegan E, Hsu H, Ferrell L, Lake J, Kim M, Combs C, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
12. Feray C, Zignego A, Samuel D, Bismuth A, Reynes M, Tiollais P, Bismuth H, et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. Transplantation 1990; 49:1155-1158.